{"rows":[{"id":2745,"title":"Further studies on oxygenated tryptamines with LSD-like activity incorporating a chiral pyrrolidine moiety into the side chain.","authors":"Gerasimov M, Marona-Lewicka D, Kurrasch-Orbaugh DM, Qandil AM, Nichols DE","journal":"Journal of medicinal chemistry","publication_date":"1999-10-07","publication_year":1999,"doi":"10.1021/jm990325u","pubmed_id":"10514296","openalex_id":"https://openalex.org/W2080691073","source_url":"https://pubmed.ncbi.nlm.nih.gov/10514296/","substance_tags":"psilocin","topic_tags":"Pharmacology,Receptor Pharmacology","study_type":"Other","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:54:14","last_checked":"2026-08-09 08:28:30","bibtex":null,"source_record_id":"PMID:10514296","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/10514296/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:10514296","source_url":"https://pubmed.ncbi.nlm.nih.gov/10514296/","doi":"10.1021/jm990325u","pmid":"10514296","publication_date":"1999-10-07","importer_version":"2.1.3","text_redistributed":false}},{"id":2733,"title":"Effect of ring fluorination on the pharmacology of hallucinogenic tryptamines.","authors":"Blair JB, Kurrasch-Orbaugh D, Marona-Lewicka D, Cumbay MG, Watts VJ, Barker EL, Nichols DE","journal":"Journal of medicinal chemistry","publication_date":"2000-11-30","publication_year":2000,"doi":"10.1021/jm000339w","pubmed_id":"11101361","openalex_id":"https://openalex.org/W1972426098","source_url":"https://pubmed.ncbi.nlm.nih.gov/11101361/","substance_tags":"psilocin","topic_tags":"Pharmacology,Receptor Pharmacology,In Vitro Study","study_type":"In Vitro Study","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:54:14","last_checked":"2026-08-09 08:28:30","bibtex":null,"source_record_id":"PMID:11101361","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/11101361/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:11101361","source_url":"https://pubmed.ncbi.nlm.nih.gov/11101361/","doi":"10.1021/jm000339w","pmid":"11101361","publication_date":"2000-11-30","importer_version":"2.1.3","text_redistributed":false}},{"id":1138,"title":"Discovery and Structure-Activity Relationships of 2,5-Dimethoxyphenylpiperidines as Selective Serotonin 5-HT Receptor Agonists.","authors":"M Ro Rsted E, Jensen AA, Smits G, Frydenvang K, Kristensen JL","journal":"Journal of medicinal chemistry","publication_date":"2024-05-09","publication_year":2024,"doi":"10.1021/acs.jmedchem.4c00082","pubmed_id":"38648420","openalex_id":"https://openalex.org/W4394993604","source_url":"https://pubmed.ncbi.nlm.nih.gov/38648420/","substance_tags":"psilocybin","topic_tags":"Depression,Anxiety,Receptor Pharmacology,Clinical Trial","study_type":"Clinical Trial","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:48:05","last_checked":"2026-08-09 08:28:09","bibtex":null,"source_record_id":"PMID:38648420","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/38648420/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:38648420","source_url":"https://pubmed.ncbi.nlm.nih.gov/38648420/","doi":"10.1021/acs.jmedchem.4c00082","pmid":"38648420","publication_date":"2024-05-09","importer_version":"2.1.3","text_redistributed":false}},{"id":472,"title":"Structure-Guided Design of Novel 5-HT Partial Agonists as Psychedelic Analogues with Antidepressant Effects.","authors":"Li R, Yan H, Chen Y, Liu Y, Tang L, Yu J, Liu J, Wang H, Wang S, Cheng J","journal":"Journal of medicinal chemistry","publication_date":"2025-10-23","publication_year":2025,"doi":"10.1021/acs.jmedchem.5c02045","pubmed_id":"41087124","openalex_id":"https://openalex.org/W4415182565","source_url":"https://pubmed.ncbi.nlm.nih.gov/41087124/","substance_tags":"psilocybin","topic_tags":"Depression,Receptor Pharmacology,Animal Study","study_type":"Animal Study","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:48:04","last_checked":"2026-08-09 08:27:55","bibtex":null,"source_record_id":"PMID:41087124","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/41087124/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:41087124","source_url":"https://pubmed.ncbi.nlm.nih.gov/41087124/","doi":"10.1021/acs.jmedchem.5c02045","pmid":"41087124","publication_date":"2025-10-23","importer_version":"2.1.3","text_redistributed":false}}],"total":4,"page":1,"per_page":20,"pages":1,"resource":"papers","filters":{"q":null,"author":null,"substances":["psilocybin","psilocin"],"topic":null,"study_type":null,"cited_doi":null,"sources":[],"publication_statuses":[],"year":null,"journal":"Journal of medicinal chemistry","from":null,"to":null,"added_from":null,"added_to":null,"sort":"newly_added","page":1,"per_page":"20"}}